Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chimeric papillomavirus-like particles

M Müller1, J Zhou, T D Reed

  • 1Department of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois 60153, USA. mmuelle@wpo.it.luc.edu

Virology
|July 21, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Growth and Performance of Perovskite Semiconductor CsPbX<sub>3</sub> (X = Cl, Br, I, or Mixed Halide) for Detection and Imaging Applications.

Materials (Basel, Switzerland)·2024
Same author

Genome Wide Conditional Mouse Knockout Resources.

Drug discovery today. Disease models·2024
Same author

A global cloud free pixel- based image composite from Sentinel-2 data.

Data in brief·2020
Same author

15 years of the model study course in medicine at the Ruhr University Bochum.

GMS journal for medical education·2019
Same author

Factors determining microbial colonization of liquid nitrogen storage tanks used for archiving biological samples.

Applied microbiology and biotechnology·2019
Same author

Evaluation of a 3D-printed total knee arthroplasty using radiostereometric analysis: assessment of highly porous biological fixation of the tibial baseplate and metal-backed patellar component.

The bone & joint journal·2019

Chimeric papillomavirus-like particles (CVLPs) were created by modifying the HPV 16 L1 protein. These CVLPs effectively induce neutralizing antibodies and show potential for peptide delivery into mammalian cells.

Area of Science:

  • Virology
  • Immunology
  • Biotechnology

Background:

  • Human papillomavirus (HPV) infections are a significant global health concern.
  • Development of effective vaccines and therapeutic strategies against HPV is crucial.

Purpose of the Study:

  • To construct and characterize chimeric papillomavirus-like particles (CVLPs) using HPV 16 L1 and E7 proteins.
  • To evaluate the immunogenicity and cellular interaction of these novel CVLPs.

Main Methods:

  • Genetic engineering of HPV 16 L1 protein with HPV 16 E7 fragments.
  • Expression of chimeric proteins using recombinant baculoviruses.
  • Analysis of CVLP assembly via electron microscopy.
  • Assessment of neutralizing antibody response through hemagglutination inhibition.

Related Experiment Videos

  • In vitro studies on cell binding and penetration.

    • Main Results:

    • High-efficiency production of CVLPs with inserts up to 60 amino acids.
    • CVLPs successfully induced a neutralizing antibody response.
    • CVLPs demonstrated hemagglutination of mouse erythrocytes, indicating interaction with papillomavirus receptors.
    • CVLPs were shown to bind to and penetrate cells in vitro.

    Conclusions:

    • CVLPs are efficiently assembled and immunogenic, capable of eliciting neutralizing antibodies.
    • CVLPs interact with cellular receptors and can enter cells, mimicking natural papillomavirus pathways.
    • CVLPs hold promise as a platform for delivering peptides into mammalian cells for potential therapeutic applications, including MHC class I presentation.